Healius Ltd (HLS)

Sydney
Currency in AUD
Disclaimer
2.370
-0.020
(-0.84%)
Closed
High dividend Yield
Day's Range
2.320
2.380
52 wk Range
2.310
3.530
Volume
617,902
Bid/Ask
2.360 / 2.370
Prev. Close
2.39
Open
2.33
Day's Range
2.32-2.38
52 wk Range
2.31-3.53
Volume
617,902
Average Vol. (3m)
1,415,505
1-Year Change
-30.21%
Shares Outstanding
569,764,147
Analysts
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
2.938
Upside +23.966%

People Also Watch

19.51
LOV
+0.41%
2.510
KAR
+1.21%
5.99
IRE
-0.83%
6.84
BAP
-1.58%
2.50
IFL
+0.81%
How do you feel today about HLS?
Vote to see community's results!
or

Healius Ltd Company Profile

Healius Limited is an Australia-based healthcare company. The Company operates through three segments: Pathology, Imaging, and Day Hospitals. The Pathology segment is a provider of pathology services. The Imaging segment is a provider of imaging and scanning services from standalone imaging sites, hospitals, and medical centers. The Day Hospitals segment is an operator of day hospitals. The Company has a network of pathology laboratories, diagnostic imaging centers, day hospitals, and In-Vitro Fertilization (IVF) clinics. It provides specialty diagnostic services to consumers and their referring practitioners, as well as supporting independent healthcare professionals in the delivery of care in its centers, day hospitals and fertility clinics. It also offers diagnostics, veterinary pathology services to veterinarians. The Company’s brands include QML Pathology, Dorevitch Pathology, QML Pathology, Western Diagnostic Pathology, and Genomic Diagnostic.

Employees
11000
Market
Australia

Income Statement